The rise and fall of DNA testing company 23andMe

The genetic testing firm 23andMe has filed for bankruptcy, another
twist in the story of a company that promised a pioneering approach
to precision health. Now users are scrambling to delete their
personal data, with the future ownership of the firm uncertain. To
understand the highs and lows of 23andMe’s journey, Madeleine
Finlay hears from the Guardian US tech reporter and editor Johana
Bhuiyan, and from Timothy Caulfield, a professor of law at the
University of Alberta, who has a special interest in health and
biotechnology. Help support our independent journalism at
theguardian.com/sciencepod